Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Neuroimage|March 15, 2006
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestRahul S Desikan, Florent Ségonne, Bruce Fischl, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 5, 2024
Dielectric Barrier Plasma Discharge Exsolution of Nanoparticles at Room Temperature and Atmospheric PressureAtta Ul Haq, Fiorenza Fanelli, Leonidas Bekris, et al.
Neuroimage|May 3, 2006
Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturerXiao Han, Jorge Jovicich, David Salat, et al.
Molecular Imaging and Biology|December 19, 2023
Evaluation and Application of a PET Tracer in Preclinical and Phase 1 Studies to Determine the Brain Biodistribution of Minzasolmin (UCB0599)Joël Mercier, Massimo Bani, Anny-Odile Colson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 2, 2019
Assessment of a white matter reference region for <sup>11</sup>C-UCB-J PET quantificationSamantha Rossano, Takuya Toyonaga, Sjoerd J Finnema, et al.
Neuroimage|February 24, 2009
MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengthsJorge Jovicich, Silvester Czanner, Xiao Han, et al.
EJNMMI Research|November 8, 2022
Drug characteristics derived from kinetic modeling: combined <sup>11</sup>C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2AMika Naganawa, Jean-Dominique Gallezot, Sjoerd J Finnema, et al.
Therapeutic Advances in Musculoskeletal Disease|December 2, 2024
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imagingXenofon Baraliakos, Jerney de Jongh, Denis Poddubnyy, et al.
Parkinsonism & Related Disorders|June 5, 2004
Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primatesAurora Fontan, Ana Rojo, Rosario Sanchez Pernaute, et al.
Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Pageof 10